drugset / Trial / NCT03483636
Study of Lemborexant-Alcohol Interaction in Healthy Subjects
RandomizedCrossoverQuadruple-blindBasic science
Summary
This study will be conducted to evaluate the effects on cognitive performance (Power of Attention domain) and postural stability of lemborexant in combination with alcohol versus lemborexant alone and versus alcohol alone in healthy participants. This study will also assess the safety and tolerability of a single oral dose of lemborexant when administered alone or in combination with alcohol in healthy participants.
Timeline
- Start
- 2018-03-12
- Primary completion
- 2018-09-12
- Completion
- 2018-09-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alcohol | Other / unclassified | 0.6 g/kg | — |
| Subject | Alcohol | Other / unclassified | 0.7 g/kg | — |
| Subject | Lemborexant | Small molecule | 10 mg | Oral |
Indications
No indication recorded.